SCHEMBL23201809

SCHEMBL23201809

COC(=O)C(Cc1ccccc1)NC1CCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.58
ATM Q13315 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
POLB P06746 3/20 0.55
GFER P55789 1/20 0.55
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
ALDH1A1 P00352 2/20 0.52
THRB P10828 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
KDM4E B2RXH2 2/20 0.50
NLRP3 Q96P20 2/20 0.49
CA12 O43570 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10935494 1.00 GAA (0.58) GAAATML3MBTL1POLBGFER
SCHEMBL29069392 0.99 GAA (0.57) GAAATML3MBTL1POLBGFER
SCHEMBL29069391 0.99 GAA (0.57) GAAATML3MBTL1POLBGFER
SCHEMBL10934286 0.97 GAA (0.58) GAAATML3MBTL1POLBGFER
SCHEMBL23201807 0.94 GAA (0.61) GAAATML3MBTL1POLBGFER
SCHEMBL10481422 0.94 GAA (0.61) GAAATML3MBTL1POLBGFER
SCHEMBL7257313 0.85 MME (0.54) POLBALDH1A1HSD17B10KDM4ELMNA
SCHEMBL12678083 0.85 MME (0.54) POLBALDH1A1HSD17B10KDM4ELMNA
SCHEMBL6439794 0.84 EPHX2 (0.56) POLBALDH1A1HSD17B10KDM4ELMNA
SCHEMBL29069408 0.84 EPHX2 (0.56) POLBALDH1A1HSD17B10KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3805237-B1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND JIANGSU CHUANGTE PHARMACEUTICAL TECH CO LTD (CN) 2026-01-28 EP disclosed
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2023-01-03 US disclosed
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2021-07-15 US disclosed
EP-3805237-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) 2021-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF SEM1, VIP, PSMB11 GAA 658/4885ATM 4037/4885L3MBTL1 2190/4885
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof SEM1, VIP, PSMB11 GAA 658/4885ATM 4037/4885L3MBTL1 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.